Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Zurl, Hanna
8  Ergebnisse:
Personensuche X
?
1

Charlson–Deyo Comorbidity Index as a Novel Predictor for Re..:

Scheipner, Lukas ; Zurl, Hanna ; Altziebler, Julia V....
Cancers.  15 (2023)  24 - p. 5770 , 2023
Link: https://doi.org/10.3390/..
 
?
2

Combining targeted and systematic prostate biopsy improves ..:

Mischinger, Johannes ; Schöllnast, Helmut ; Zurl, Hanna...
Frontiers in Surgery.  9 (2022)  - p. , 2022
Link: https://doi.org/10.3389/..
 
?
3

Evaluation of the new cobas® HCV genotyping test based on r..:

Stelzl, Evelyn ; Appel, Hannah M. ; Mehta, Rochak...
Clinical Chemistry and Laboratory Medicine (CCLM).  55 (2017)  4 - p. , 2017
Link: https://doi.org/10.1515/..
 
?
4

Charlson–Deyo Comorbidity Index as a Novel Predictor for Re..:

Scheipner, Lukas ; Zurl, Hanna ; Altziebler, Julia V...
https://resolver.sub.uni-goettingen.de/purl?gro-2/139844.  , 2023
Link: https://resolver.sub.uni..
 
?
5

Combining targeted and systematic prostate biopsy improves ..:

Mischinger, Johannes ; Schöllnast, Helmut ; Zurl, Hanna...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582510/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
6

Combining targeted and systematic prostate biopsy improves ..:

Mischinger, Johannes ; Schöllnast, Helmut ; Zurl, Hanna...
https://opus.bibliothek.uni-augsburg.de/opus4/frontdoor/index/index/docId/101492.  , 2022
Link: https://opus.bibliothek...
 
?
7

Charlson–Deyo Comorbidity Index as a Novel Predictor for Re..:

Lukas Scheipner ; Hanna Zurl ; Julia V. Altziebler...
https://www.mdpi.com/2072-6694/15/24/5770.  , 2023
Link: https://doi.org/10.3390/..
 
?
8

Combining targeted and systematic prostate biopsy improves ..:

Johannes Mischinger ; Helmut Schöllnast ; Hanna Zurl...
https://www.frontiersin.org/articles/10.3389/fsurg.2022.1013389/full.  , 2022
Link: https://doi.org/10.3389/..
 
1-8